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Abstract: The requirement for vitamin A in reproduction was first recognized in the early 
1900’s, and its importance in the eyes of developing embryos was realized shortly after. 
A greater  understanding  of  the  large  number  of  developmental  processes  that  require 
vitamin A emerged first from nutritional deficiency studies in rat embryos, and later from 
genetic studies in mice. It is now generally believed that all-trans retinoic acid (RA) is the 
form of vitamin A that supports both male and female reproduction as well as embryonic 
development. This conclusion is based on the ability to reverse most reproductive and 
developmental  blocks  found  in  vitamin  A  deficiency  induced  either  by  nutritional  or 
genetic means with RA, and the ability to recapitulate the majority of embryonic defects in 
retinoic  acid  receptor  compound  null  mutants.  The  activity  of  the  catabolic  CYP26 
enzymes in determining what tissues have access to RA has emerged as a key regulatory 
mechanism,  and  helps  to  explain  why  exogenous  RA  can  rescue  many  vitamin  A 
deficiency defects. In severely vitamin A-deficient (VAD) female rats, reproduction fails 
prior to implantation, whereas in VAD pregnant rats given small amounts of carotene or 
supported on limiting quantities of RA early in organogenesis, embryos form but show a 
collection  of  defects  called  the  vitamin  A  deficiency  syndrome  or  late  vitamin  A 
deficiency. Vitamin A is also essential for the maintenance of the male genital tract and 
spermatogenesis. Recent studies show that vitamin A participates in a signaling mechanism 
to  initiate  meiosis  in  the  female  gonad  during  embryogenesis,  and  in  the  male  gonad 
postnatally. Both nutritional and genetic approaches are being used to elucidate the vitamin 
A-dependent pathways upon which these processes depend. 
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1. Background 
It  has  been  nearly  100  years  since  the  essential  micronutrient,  vitamin  A,  was  first  described. 
In 1913 McCollum and Davis reported that the addition of an ether extract from egg yolk or butter, but 
not lard or olive oil, could reinstate growth in rats maintained for several months on a purified ration of 
casein,  carbohydrates  and  salt  mixtures  [1].  We  now  know  that  this  essential  accessory  article  in 
foodstuffs is vitamin A. Using dietary manipulation to induce deficiency in rats, the importance of 
vitamin A in both male and female reproduction was soon discovered [2,3]. For a time, there was 
confusion over how both yellow-colored foods and those that were colorless, for example extract from 
pork liver or cod liver oil, could both yield vitamin A activity [4]. This problem was solved when 
Moore fed carotenoids to vitamin A-deficient (VAD) rats in amounts that enabled the animals to 
resume normal growth, and showed that only the ―colorless‖ form of vitamin A was found in the livers 
collected from these animals [5]. Thus, it was realized that carotenoids (at least a subset) could be 
converted to vitamin A, a fact that was fully appreciated when Karrer et al. published the chemical 
structures of both carotene and vitamin A [6,7]. In 1946, Arens and van Dorp synthesized vitamin A 
acid (retinoic acid), and reported it was as potent as vitamin A in supporting the growth of VAD rats 
but could not be converted back to vitamin A  [8–10]. The metabolic scheme in which vitamin A 
(retinol) generates the vitamin A aldehyde (retinaldehyde) to support synthesis of the visual pigments, 
and its further irreversible oxidation to the vitamin A acid (all-trans retinoic acid, RA) that supports 
growth and tissue maintenance was first reported in the landmark paper by Dowling and Wald and this 
metabolic scheme stands essentially unchanged today (Figure 1A) [11].  
All-trans retinol (retinol, vitamin A) is obtained in the diet from plant sources (carotenoids with 
vitamin  A  activity)  or  as  retinyl  esters  from  animal  sources.  Retinol  has  two  major  fates:  
(1) esterification and tissue storage, and (2) oxidative metabolism to all-trans retinaldehyde and further 
oxidation to RA. The enzyme lecithin:retinol acyltransferase (LRAT) is responsible for esterifying the 
majority of retinol into retinyl esters [12]. The first and rate-limiting step in the production of RA from 
retinol results from the action of cytosolic alcohol dehydrogenases (ADH) and microsomal retinol 
dehydrogenases (RDH) yielding all-trans retinaldehyde [13]. The irreversible oxidation of all-trans 
retinaldehyde to all-trans retinoic acid is catalyzed by several aldehyde dehydrogenases (RALDH),  
of  the  ALDH1A  class  (ALDH  1A1,  1A2,  and  1A3  also  known  as  RALDH  1,  2  and  3)  [14,15].  
RALDH-independent  generation  of  RA  from  retinol  by  CYP1B1  has  also  been  reported  [16].  
The metabolism of RA at the C4 and C18 positions to oxidative metabolites including 4-hydroxy-RA, 
18-hydroxy-RA, and  4-oxo-RA occurs  by the action of cytochrome P450 enzymes of the CYP26 
family  (A1,  B1  and  C1)  [17–23].  Vitamin  A  and  metabolites  are  lipophilic  compounds  that  are 
generally found in association with serum and cellular binding proteins [24]. Retinol-binding protein 
(RBP or RBP4) carries the majority of retinol in the circulation [25], and a membrane receptor, STRA6, 
binds to RBP to enable efficient retinol uptake by a number of cells [26]. In addition, cellular proteins 
that bind to retinol (CRBP I, II, and III), and RA (CRABP I and II) have been studied in null mutant Nutrients 2011, 3  
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mice; some have been found to be dispensable, while roles for others have been revealed when animals 
are fed a vitamin A-restricted diet [12,27,28]. 
Figure  1.  Metabolism  of  vitamin  A  (retinol)  to  all-trans  retinoic  acid  (RA),  and  the 
mechanism  of  RA  action.  (A)  Metabolic  scheme  proposed  by  Dowling  and  Wald  in 
1960 [11]; (B) Mechanism ca. 2011. Vitamin A (retinol, ROL) circulates bound to the 
plasma retinol-binding protein (RBP4) and transthyretin (not shown). RBP4 binds to the 
membrane  receptor  STRA6  to  facilitate  the  cellular  uptake  of  retinol  in  some  cells. 
Vitamin A circulating as part of a chylomicron remnant (CMRE) can also serve as a source 
of vitamin A for the cell. Note that cellular retinol and RA binding proteins have been 
omitted for simplicity. Retinol is either esterified by lecithin:retinol acyltransferase (LRAT) 
and stored, or is oxidized reversibly to retinaldehyde (RAL) by retinol dehydrogenases 
(RDH/ADH),  and  further  oxidized  in  irreversible  fashion  to  RA  by  retinaldehyde 
dehydrogenase (RALDH 1, 2, or 3). In the nucleus, the RAR/RXR complex is bound to a 
specific sequence of DNA called the retinoic acid response element (RARE). Binding of 
RA to the RAR leads to release of the corepressor complex (CoRep) and association with 
coactivator proteins (CoAct), followed by altered transcription of downstream target genes 
and ultimately changes in cellular function. RA also undergoes further oxidation by the 
cytochrome P450 (CYP) 26 family to more polar metabolites. The lipophilic molecule, 
RA, can act within the same cell in which it is synthesized (autocrine) or can diffuse 
through the cell membrane to act in nearby cells (paracrine). Abbreviations: ADH, alcohol 
dehydrogenase; RDH, retinol dehydrogenase; REH, retinyl ester hydrolase; RE, retinyl ester. 
 Nutrients 2011, 3  
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RA is a ligand for the nuclear retinoic acid receptor (RAR) proteins. There are three major subtypes 
of RAR protein (α, β and γ) with additional isoforms resulting from alternate promoter usage and 
splicing  [29].  The  nuclear  RARs  act  as  ligand-activated  transcription  factors  to  regulate  gene 
transcription in a cell-type and tissue-specific manner [30]. The all-trans isomer of RA is the highest 
affinity  endogenous  ligand  for  the  RAR  [31].  Members  of  a  second  protein  family,  the  retinoid 
(rexinoid)-X receptors (RXR) heterodimerize with RAR to confer high-affinity binding to DNA. The 
DNA to which the RAR/RXR heterodimer binds is called a retinoic acid response element (RARE). 
The consensus RARE is composed of two direct repeats of PuG(G/T)TCA separated most often by 
5 bases [32]. However, more complex elements that do not adhere to this rule have been described [33]. 
RAREs  serve  as  enhancer  elements  and  when  occupied  by  the  RA/RAR/RXR  complex,  facilitate 
chromatin opening and changes in RA target gene transcriptional activity [34,35]. A large number of 
genes are altered when cells or tissues are exposed to RA, however, only a small subset are primary 
(direct)  targets  via  RARE-mediated  transcription,  with  the  remainder  representing  downstream 
targets [36,37]. A schematic summarizing the metabolism of vitamin A and the cellular mechanism of 
RA action is shown in Figure 1B. Note in this review retinoid is a term that refers to compounds 
structurally-related to retinol, and in this review, is used to refer to vitamin A and its metabolites. 
2. Vitamin A and Reproduction 
2.1. Male Reproduction 
Vitamin A is required for male reproduction. Early work in the laboratories of Wolbach and Howe 
as well as Mason showed that in vitamin A deficiency, the epithelia of the epididymis, prostate, and 
seminal  vesicle  is  replaced  with  stratified  squamous  keratinizing  epithelium,  and  spermatogenesis 
ceases [2,38]. Later work showed that in the VAD rat testes, undifferentiated spermatogonia, Sertoli 
cells  and  a  small  number  of  preleptotene  spermatocytes  remain  [39–41],  whereas  in  the  mouse, 
spermatogenesis  is  arrested  at  the  spermatogonia  stage  [42].  Upon  addition  of  vitamin  A, 
spermatogenesis  can  be  reinstituted  by  stimulating  A  to  A1  spermatogonial  differentiation  in  a 
synchronized manner [42–44]. The block in adult spermatogenesis resulting from vitamin A deficiency 
is shown in Figure 2. Recent work supports the conclusion that the vitamin A metabolite, RA, is 
needed both for adult male spermatogonial differentiation (transition to A1) and the entrance into 
meiosis [45–47].  
In 1991, Van Pelt and de Rooij determined that a large dose of RA (5 mg) given by injection twice 
a week, when combined with a RA-containing diet, supported the development of spermatocytes, and 
their subsequent development into spermatids in VAD rats supporting that RA is the active form of 
vitamin A in male reproduction [48]. A CYP26-mediated catabolic barrier comprised of peritubular 
myoid cells surrounds the seminiferous tubule, and may prevent RA in the general circulation from 
reaching cells in the interior of the tubule, thus explaining why such high doses of exogenous RA were 
required [49,50]. Within the normal tubule, the Sertoli cell is believed to generate RA by the action of 
Raldh1 [49,51,52], and possibly Raldh2 [50]. Raldh2 is also found in late pachytene and diplotene 
spermatocytes, and early stage spermatids.  Nutrients 2011, 3  
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Figure 2. Spermatogenesis in the adult. Spermatogenesis takes place in the seminiferous 
epithelium  of  testis  tubules  from  puberty  through  adulthood.  Undifferentiated  (A-type) 
spermatogonia at the base of the seminiferous epithelium divide mitotically until they enter 
the  differentiation  pathway  to  become  A1  spermatogonia.  A1  spermatogonia  undergo 
division  to  A1–A4  and  finally  B  spermatogonia.  B  spermatogonia  divide  to  produce 
preleptotene (primary) spermatocytes that migrate away from the base of the seminiferous 
tubule to undergo meiosis. The first meiotic division produces secondary spermatocytes, 
and after the second meiotic division, spermatids (haploid cells) begin the differentiation 
process (spermiogenesis) to spermatozoa. In vitamin A deficiency, the transition from A to 
A1 spermatogonia is blocked [42–44].  
 
RARγ null males are sterile and exhibit squamous metaplasia of the seminal vesicles and prostate 
glands  [53].  RARα  null  mutants  are  sterile  and  show  a  reduction  in  spermatozoa,  indicating  that 
nuclear RAR is needed for spermiation [54]. RARα is expressed primarily in the Sertoli cell, Rarβ in 
spermatids and RARγ in A spermatogonia [49]. Expression of RARα is needed for differentiation of 
the spermatogonia during prepuberty [55]. However, RAR signaling in the Sertoli cell cannot account 
for the VAD-induced arrest in spermatogonia differentiation, as deletion of all RARs in the Sertoli  
cell  does  not  cause  arrest  of  spermatogonia  differentiation  in  the  adult  mouse.  The  cell  types  
in  which  RA and  its  receptors  act to  support  spermatogenesis  continues  to  be  a  subject  of  active 
investigation [45,49,55–57].  
2.2. Female Reproduction 
In the female, the effect of vitamin A deficiency on reproductive outcome is dependent upon the 
time when deficiency is imposed, as well as its severity [58]. When severe vitamin A deficiency is 
imposed  prior  to  mating,  cornified  cells  are  continuously  present  in  vaginal  smears  [59,60]  and 
reproduction fails prior to implantation [3]. VAD female rats continue to ovulate and form corpora Nutrients 2011, 3  
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lutea irregularly or at normal intervals, however, degenerated eggs are found in the last portion of the 
tube, and there is no evidence that blastogenesis has occurred. 
Warkany and Schraffenberger showed that when limited amounts of provitamin A carotenoid are 
provided to VAD female rats prior to mating, a less severe maternal vitamin A deficiency is produced 
which  enables  fertilization  and  implantation  to  occur,  but  embryonic  death  at  midgestation  often 
results  [61].  If  provided  in  adequate  amounts,  retinol  will  support  reproduction  and  embryonic 
development in full [62]. RA in amounts ranging from 2 to 12 mcg/g diet or 40 to 230 mcg/rat/day 
given  to  a  VAD  female  rat  is  sufficient  to  maintain  normal  fertilization,  implantation  and  early 
embryogenesis. However, pregnant animals maintained on this level of RA will invariably resorb all 
the fetuses. Higher amounts of RA (250 mcg/g diet or approximately 4.5 mg/rat/day) or retinol is 
needed  by  embryonic  day  8.5  (E8.5)  (late  gastrula/early  neurula)  to  support  normal  embryonic 
development and overcome midgestational resorption [63–67]. 
Maternal  vitamin  A  also  plays  a  role  in  placental  development  and/or  maintenance,  as  the 
chorioallantoic  placenta  undergoes  widespread  necrosis  by  E15.5  in  VAD  rats  supported  on 
insufficient  amounts  of  RA  [68].  Microscopic  analysis  of  the  placenta  from  E14  to  E17  reveals 
changes in the central region of the junctional zone and the labyrinthine zone of VAD rats supported 
on  insufficient  vitamin  A  acid,  whereas  addition  of  retinyl  acetate  to  the  diet  prevents  these 
changes [69].  Microscopic  findings  suggest  the  differentiation  of  the  parenchymal  cells  of  the 
junctional zone to glycogen cells, and of the chorionic trophoblast cells to the inner trophoblastic 
lamina of the trichorial placenta is affected. In summary, the relative vitamin A status of the female, 
both at the time of conception and throughout pregnancy, is a critical determinant in reproductive 
outcome, and deficiency can lead to either a complete failure of reproduction prior to implantation or 
fetal resorption or malformation. 
2.3. Germ Cell Development 
The generation of sperm and oocytes requires germ cells to undergo meiosis, the process in which 
diploid cells give rise to haploid cells. In the female, germ cells enter meiosis I during embryogenesis, 
whereas in the male, this process occurs postnatally (Figure 3A). It has been proposed that access of 
primordial germ cells (gonocytes) to RA plays an important role in determining when they will enter 
meiosis, with female germ cells entering into meiosis after exposure to embryonic RA, whereas, in the 
male embryo, this pathway is blocked by the action of CYP26B1, but is enabled after birth [70–73]. 
However, a report appearing when this manuscript was under review raises questions concerning a role 
for RA in this model [74]. 
The  culture  of  embryonic  rat  ovaries  with  RA  promotes  meiotic  entry  [75],  whereas  murine 
embryonic ovaries (E11.5) cultured in the presence of the RAR panantagonist BMS-204493 for 2 days 
do not express the RA-responsive gene Stra8 [70], a gene that is required for meiotic initiation in 
female  gonocytes  [76].  However,  a  recent  report  shows  that  female  RALDH2  and  RALDH2/3 
knockout  gonads  express  Stra8  and  undergo  meiosis  in  the  absence  of  detectable  RA  activity  as 
assessed using a β2-RARE-lacZ (RARE-lacZ) reporter [74]. If the reporter accurately detects all RA 
activity, this new work indicates that meiotic initiation can occur independently of RA signaling.  Nutrients 2011, 3  
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Figure 3. (A) Germ cell development and gametogenesis. Primordial germ cells colonize 
the gonad in both male and female embryos. The first morphological marker of sex-specific 
germ cell  development is  seen in the  female  embryo when the oogonia enter  meiosis. 
Primary oocytes proceed through the leptotene, zygotene and pachytene stages of meiotic 
prophase before birth, when they arrest in diplotene of meiosis I. At ovulation, meiosis I is 
completed,  and  the  secondary  oocytes  enter  meiosis  II  and  arrest  again  in  metaphase. 
Meiosis II is completed after fertilization. In the male embryo, germ cells are committed to 
the spermatogenic program but arrest in G0/G1, and do not complete mitosis and enter 
meiosis until after they are born. Primary spermatocytes entering meiosis I are seen during 
the first week of life; secondary spermatocytes complete meiosis II forming spermatids and 
functional gametes called spermatozoa or sperm. In the male, waves of meiosis continue 
throughout life. (B) In the female embryo access to RA or alternatively, another factor 
indicated  as  (?),  promotes  entry  into  meiosis  whereas  embryonic  male  germ  cells  are 
maintained in a pluripotent state. Either RA or another factor acts in the embryonic female 
germ cell to increase Stra8, essential for entry into meiosis. In the ovary, Fgf9 levels are 
low. In the male embryo, entry into meiosis is prevented by the action of CYP26B1; high 
levels  of  Fgf9  in  the  testes  antagonize  Stra8  expression  and  maintain  germ  cells  in  a 
pluripotent state. (Adapted from [77,78]). 
 
There is clear in vivo evidence that vitamin A is required for the normal onset of meiotic prophase 
in  ovarian  germ  cells  [79].  While  fetal  ovarian  germ  cell  number  is  unaffected  by  vitamin  A 
deficiency, the germ cells in embryos with the most severe vitamin A deficiency fail to enter meiosis 
as  evidenced  by  a  lack  of  immunostaining  for  SYCP3  (a  gene  that  encodes  a  component  of  the Nutrients 2011, 3  
 
392 
synaptonemal  complex),  and  the  critical  RA-responsive  gene,  Stra8  is  nearly  undetectable.  
When RA is included in the maternal diet at a slightly higher level, but one insufficient to support most 
other  vitamin  A-dependent  embryonic  processes,  a  small  number  of  cells  undergo  meiosis  (30%) 
compared to 75% of cells in the vitamin A-sufficient group. Thus, it is possible that only a very low 
level of RA is needed to initiate meiosis, or alternatively, vitamin A may support meiotic entry by an 
alternative mechanism. 
The mesonephros has been proposed as the source of RA that initiates the entry of primordial 
gonocytes into meiosis [71]. Raldh2 is largely responsible for RA synthesis in the mesonephros, with 
some contribution from Raldh3 in the region of the mesonephric duct [71,80]. Expression of Raldh1 
mRNA is reported in the adjacent male gonad from E11.5 to 13.5, and to a lesser extent in the female 
gonad by E13.5 [81]. The gene encoding the RA-metabolizing cytochrome P450 enzyme, Cyp26b1, is 
expressed early in the genital ridge, but is decreased after E12.5 in the female mouse embryo, thus 
enabling access of the gonocyte to RA [71]. In contrast, the expression of Cyp26b1 persists in the male 
embryonic gonad, and has been proposed to prevent RA from stimulating the gonocytes to undergo 
meiosis [70,71]. Embryonic male germ cells undergo G0/G1 mitotic cell cycle arrest and do not enter 
meiosis until a week after birth. In CYP26B1 null mutant male embryos, RA levels in the testes are 
increased and germ cells prematurely enter meiosis at embryonic day 13.5, and this is followed by 
apoptosis  [73].  CYP26B1  is  also  required  later  in  embryogenesis  to  maintain  cells  in  an 
undifferentiated  state  [82].  However,  a  new  report  shows  that  inhibition  of  CYP26  activity  with 
ketoconazole results in a similar increase in Stra8 mRNA in cultured wild-type and RALDH2 null 
mutant testis/mesonephros complexes, whereas no expression is seen in testes cultured in isolation [74]. 
This suggests that some factor other than RA from the mesonephros may be affected by CYP26, and 
thus  control  entry  into  meiosis.  Thus,  either  a  very  low  level  of  RA  that  is  undetectable  by  the  
RARE-lacZ reporter and that is generated by an enzyme other than RALDH2 is responsible for meiotic 
entry, or alternatively, CYP26B1 functions by degrading an unknown inducer of Stra8 or participates 
in the synthesis of a factor that inhibits Stra8 expression.  
Recently, Li et al. showed that vitamin A is required in the male neonate for germ cells to enter the 
first  round  of  spermatogenesis  [83].  Vitamin  A  deficiency  was  produced  in  prepubertal  life  by 
maintaining LRAT
−/− female mice on a diet devoid of all vitamin A during pregnancy and lactation.  
It was possible to generate deficiency at this time because LRAT
−/− mice cannot store retinol in the 
form of retinyl esters in most tissues, and thus the mothers and pups can be more rapidly depleted of 
their vitamin A stores than wild-type mice. In the wild-type mouse, Stra8 begins to increase in the 
testis by postnatal day 6 [84] and spermatogenesis begins shortly thereafter [85]. However, in the VAD 
LRAT
−/− gonad the expected increase in Stra8 did not occur. Germ cells, although present in normal 
numbers, did not undergo meiosis as was observed in the vitamin A-sufficient controls and instead 
remained  undifferentiated  [83].  The  addition  of  retinol  to  VAD  LRAT
−/−  pups  at  postnatal  day  5 
prevented meiotic failure. Thus, it appears that an environment depleted of vitamin A maintains germ 
cells in an undifferentiated state, and vitamin A sufficiency enables entry into meiosis I in both the 
developing female and male gonad.  Nutrients 2011, 3  
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3. Vitamin A and Embryonic Development 
3.1. Embryonic Vitamin A Deficiency Studies 
Very early evidence that vitamin A is required for embryonic development came from reports of 
abnormalities in pigs born to gilts on a VAD diet [86,87]. A range of reproductive outcomes were 
reported in gilts fed a vitamin A-free ration from 160 days before breeding and for 30 days thereafter. 
Some  gilts  on  the  deficient  diet  failed  to  show  the  symptoms  of  estrous,  whereas  others  became 
pregnant,  but  resorbed  all  the  fetuses.  The  remaining  offspring  from  litters  that  survived  to  term 
showed a lack of eye development or no eyes. Cleft palate, accessory ears and arrested ascension of 
the kidneys were also observed, but at a lower frequency. In the 1940’s, Warkany and colleagues 
published their landmark studies describing a syndrome of defects in rat embryos from VAD mothers 
given  limited  amounts  of  carotene  [61,88–95].  Approximately  70%  of  the  VAD  female  rats 
supplemented in this fashion conceived, however, the majority of pregnancies did not continue beyond 
midgestation  [61].  Ocular  defects  were  most  frequently  observed  in  offspring  from  the  few 
pregnancies  that  progressed  to  term.  In  order  to  understand  how  maternal  vitamin  A  deficiency 
affected development, fetuses ranging from embryonic days 12.5 to 20.5 (near term) were taken by 
cesarean section whenever evidence of maternal bleeding was observed, and histology was performed. 
Of the fetuses recovered in this fashion, defects in eye development were most frequent (49% with one 
or more abnormality) and included coloboma, retinal eversion, penetration of the retina by mesodermal 
tissue, low insertion of the optic stalk and the cup, and defects in the iris. Defects at lower penetrance 
were noted in other systems including the genitourinary tract (42%), kidney (38%), diaphragm (31%), 
lung (4%), aortic arch (9%) and heart (4%) [95]. The low penetrance of many of these defects likely 
resulted from variation both in the timing and severity of maternal vitamin A deficiency.  
Taking  advantage  of  the  fact  that  RA  will  support  early  fetal  development  in  VAD  rats  [65],  
See et al. was able to generate the previously described vitamin A deficiency syndrome in 100% of 
fetuses (with the exception of cardiovascular defects) from mothers supported on a sufficient amount 
of RA up to E10.5, and fed a suboptimal amount of RA thereafter (late VAD rat model, Table 1) [67]. 
Rapid initiation of VAD is possible using this approach because RA, unlike retinol, is not stored and 
has  a  very  short  biological  half-life.  The  low  penetrance  of  cardiovascular  defects  was  due  to 
institution of deficiency after aortic arch and septal development had largely been completed. The 
addition of retinol after E10.5 prevented all fetal anomalies from appearing, and the addition of a 
higher level of RA led to either a complete or partial rescue of fetal anomalies, supporting the idea that 
RA is the functional form of vitamin A in embryonic development. Using nutritional models in which 
RA deficiency is imposed either early, or after the 12–15 somite stage, a number of defects have been 
added to the original fetal vitamin A deficiency syndrome. Nervous system, cardiovascular, and axial 
patterning defects result from early deficiency [63–66,96], whereas a less well-developed nasal region, 
salivary gland hypoplasia, agenesis of the Harderian glands, hypoplasia of the intestinal villi and a 
number of skeletal abnormalities arise if RA is limiting at later times [67]. Nutrients 2011, 3  
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Table  1.  Summary  of  abnormalities  in  VAD  rat  embryos  given  insufficient  RA  (late  
VAD)  *  [67],  insufficient  carotene  (VAD  syndrome)  [95],  or  observed  in  RAR  null 
mutants [97–99]. 
  Late VAD  VAD syndrome 
Observed in RAR 
null mutants 
Ocular  100%  49%  Yes 
Types       
Eversion of retina  100%  27%  Yes 
Fibrous retrolenticular membrane  100%  49%  Yes 
Coloboma  100%  18%  Yes 
Heart—interventricular septal defect  17%  4%  Yes 
Lung—hypoplasia  100%  4%  Yes 
Diaphragmatic hernia  100%  31%  Yes 
Intestinal villi hypoplastic  83%  Not reported  Not reported 
Kidney  100%  38%  Yes 
Types       
Kidneys too close or fused  100%  20%  Not reported 
Ectopia  100%  4%  Yes 
Ureter—ectopic termination  100%  36%  Yes 
Undescended testes  100%  54%  Not reported 
Skeletal defects  100%  Not reported  Yes 
Glandular defects  100%  Not reported  Yes 
Nasal region less developed  100%  Not reported  Yes 
* Dietary RA restricted after E10.5 (12–15 somite stage) of development. 
3.2. Role of the Retinoic Acid Receptors  
The Rars are widely expressed in development [100]. A series of genetic experiments revealed the 
importance of the RAR in mediating the actions of RA in developing embryos [99,101,102]. These key 
experiments  showed  that  compound  RAR  mutants  die  either  in  utero  or  shortly  after  birth,  and 
recapitulate most of the defects described as part of the vitamin A deficiency syndrome [61,88–95,103] 
and  the  late  VAD  rat  embryo  model  [67,104].  These  genetic  studies  provide  clear  evidence  that  
the  vitamin  A  metabolite,  RA,  acts  through  a  RAR  signaling  mechanism  in  support  of  normal 
embryonic development.  
RAR/RXR heterodimers form the functional unit that transduces the RA signal, with one genomic 
copy  of  the  Rxrα  sufficient  to  support  RXR  function  in  embryogenesis  [105].  Ocular  defects  are 
present  in  some  RXRα  mutants  lacking  only  the  AF-2  domain  (activation  function)  in  the  
ligand-binding domain [99,106,107]. However, work from the Duester group indicates that  ligand 
binding to the RAR is sufficient to transduce the signal, as a RAR- but not a RXR- selective ligand is 
able to rescue the developmental defects in RALDH2 null mutant embryos [108]. Thus, the need for a 
RXR ligand in RAR-driven events remains to be established. Nutrients 2011, 3  
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3.3. Transport of Retinoid from Maternal to Fetal Compartment  
There are at least two ways in which retinoid is transferred from the maternal blood to the fetus. 
The  major  form  of  transport  is  the  binding  of  retinol  to  a  specific  binding  protein  (RBP  or 
RBP4) [109,110]. Retinyl esters can also be transported in the form of chylomicron remnants or as a part 
of very low-density and low-density lipoproteins. During early placentation, RBP is localized in the 
endoderm of the yolk sac visceral wall surrounding the embryo, and after definitive placentation, in the 
yolk sac membranes as well as in the uterus (decidua basalis) [111,112]. RBP does not cross the placenta 
into the fetal circulation [113]. Maternal retinol must be transferred to fetal RBP [114], or alternatively, 
retinol may be esterified in the placenta, and delivered to tissues in lipoproteins [115,116]. Although 
RBP null mutant embryos from null mutant mothers develop normally on a vitamin A-sufficient diet, 
embryogenesis is perturbed when maternal vitamin A intake is restricted [110]. Thus, when RBP is not 
present, circulating retinyl ester appears to represent the main pathway for the provision of retinoid 
from mother to embryo, provided maternal vitamin A intake is adequate [113]. 
3.4. Embryonic RA Synthesis and Catabolism 
It is clear that RA is essential for embryonic development. However, too much RA at critical stages 
can result in embryo lethality or malformation [117–120]. Thus, regulation of the amount of RA that is 
available to the embryo at specific times and to a given tissue site is of critical importance. Both the 
distribution and function of enzymes involved in RA synthesis and degradation have been studied 
intensively in developing embryos. Interestingly, both the levels and domains of Cyp26 gene expression 
in the developing embryo are affected by retinoid status, whereas the Raldhs are unaffected [121].  
Of  the  retinol  dehydrogenase  enzymes,  RDH10  plays  a  key  role,  as  loss  results  in  embryonic 
lethality by approximately E13.0 [122]. These embryos (trex mutants) show a spectrum of defects 
consistent  with  vitamin  A  deficiency,  although  they  do  not  die  as  early  in  gestation  as  severely  
RA-depleted embryos [65,123], indicating that one or more additional enzymes must also be active in 
generating  retinaldehyde  for  RA  synthesis.  Supplementation  with  RA  rescues  the  abnormalities, 
supporting a role for RDH10 in RA biosynthesis. A recent detailed examination of Rdh10 in the avian 
embryo  shows  that  the  expression  domain  is  often  smaller  than  that  of  the  corresponding  Raldh, 
leading the authors to suggest that retinaldehyde may be transferred between cells [124]. Recent work 
in Xenopus shows that RA down regulates XRDH10 transcripts, and this may serve as an additional 
mechanism to regulate endogenous retinoid levels [125]. Adh 1, 3 and 4 enzyme family members are 
also  expressed  in  developing  embryos  [126,127],  however,  mutation  does  not  result  in  embryo 
lethality [128,129]. It should be noted, that ADH3 and ADH4 null mutant mice do undergo early 
postnatal lethality if maintained for two generations on a VAD diet [129]. Thus, to date, RDH10 is the 
only  retinol  dehydrogenase  shown  to  be  indispensable  for  embryonic  development  under  normal 
dietary conditions. 
Numerous  retinaldehyde  dehydrogenase  single  and  compound  deletion  mutants  have  been 
generated and studied [123,130–135]. Deletion of RALDH2 is lethal early in development, whereas 
RALDH3 null mutants die at birth [131], and RALDH1 mutants are viable [133]. Thus, RALDH2 is 
the earliest expressed family member to produce RA in the embryo, and is believed responsible for all Nutrients 2011, 3  
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RA signaling activity from E7.5–E8.5 in the mouse [136]. Shortly thereafter, RALDH1 and RALDH3 
contribute to RA synthesis in the eye and olfactory pit. Cyp1B1 can also generate RA and is expressed 
at known sites of RALDH-independent retinoid signaling [16], however, null mutant mice for this 
gene are viable [137]. Recent work in zebrafish indicates that the availability of retinaldehyde for RA 
synthesis may represent another point of control, with a short-chain dehydrogenase/reductase family 
member, DHRS3a, which catalyzes reduction of retinaldehyde to retinol serving as a RA-induced 
feedback inhibitor of RA biosynthesis [138]. 
The importance of CYP26 enzymes in restricting RA distribution and availability is illustrated by 
studies in which one or more is genetically ablated. Mutation of Cyp26A1 is embryonic lethal and 
mutants die during mid- to late gestation with symptoms mirroring those observed in RA toxicity 
including  caudal  defects  and  occasionally  exencephaly  [139–141].  CYP26B1  null  mutants  die 
immediately after birth and exhibit limb, male germ cell, and craniofacial abnormalities [73,142,143]; 
whereas loss of CYP26C1 alone does not produce an overt phenotype [144]. Deletion of both mouse 
CYP26 A1 and C1 is lethal at E9.5 to E10.5 [144], and deletion of all three CYP26 family members in 
the mouse is also lethal early in embryonic life, and produces a duplication of the body axis [145]. 
Thus, CYP26 enzymes play a very early and important role in regulating access of the embryo to RA. 
3.5. RA in the Early Embryo 
Using direct identification by HPLC, all-trans retinaldehyde is detected in embryos as early as the 
egg cylinder or pre-primitive streak stage, whereas RA is detected between the mid-primitive streak 
stage and the late allantoic bud stage [146]. Expression of a β2-RARE-lacZ (RARE-lacZ) transgene that 
is activated in reporter mice when retinoid interacts with the RAR, has been used extensively as a 
marker of retinoid-signaling activity in vivo [147]. In the post-implantation embryo, definitive staining 
is noted throughout the length of the primitive streak and the appearance of staining is coincident with 
formation of the neural plate. The time of initiation of RA synthesis within the embryo proper has also 
been deduced from studies of retinaldehyde dehydrogenase mRNA (Raldh2). It is first detected at the 
mid-primitive streak stage adjacent to the node and primitive streak [148,149]. The early activity of 
Raldh2 in the embryo, along with expression in the visceral endoderm (extraembryonic) is required for 
vascular development in both the embryo proper, as well as the yolk sac [150–152]. Prior to this time 
RA in the embryo is believed to be of maternal origin [145]. HPLC studies of embryonic tissues at 
later times confirm that all-trans retinol and RA are the primary retinoids detected, with retinol clearly 
the most abundant [153–155]. 
The importance of protecting the embryo from RA at times when it is not needed is highlighted by 
recent work on embryos null for all three CYP26 family members. RA is available from the maternal 
circulation, and Raldh2 is expressed in the endometrial stroma and decidua [156]. Raldh2 is highly 
expressed  in  the  endometrial  stroma  by  E2.5,  remains  high  after  implantation,  and  expression  is 
reduced as stromal cells undergo decidualization. Uehara et al. report that the developing embryo is 
protected from maternal sources of RA by Cyp26 family members expressed in extraembryonic cell 
types including extraembryonic endoderm and ectoderm, visceral endoderm and ectoplacental cone 
that  surround  the  murine  embryo  proper  at  E5.5  and  E6.25  [145].  When  all  three  CYP26  family 
members are deleted, embryos show a duplication of the body axis resulting from expanded Nodal Nutrients 2011, 3  
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expression driven by RA throughout the epiblast. LacZ staining that results from RA-driven expression 
of the RARE-lacZ reporter is not normally detected in wild-type embryos at E6.25, but is abundantly 
expressed in CYP26A1/B1/C1 triple knockout embryos. Thus, the CYP26 catabolic enzymes play a 
key role in regulating the exposure of the early embryo to maternal RA. 
3.6. Early Nervous System Development 
Vitamin A is required for many aspects of nervous system development including patterning and 
neural differentiation [157,158]. One of the best-studied functions of RA is in the developing hindbrain 
where it contributes to the anteroposterior patterning of the neural plate [159]. When induced, the 
neural plate is initially anterior or forebrain-like. Induction of more posterior domains occurs by the 
actions  of  RA,  Wnts  and  FGFs,  with  RA  specifying  the  posterior  hindbrain  and  cervical  spinal 
cord [160]. Patterning in the vertebrate hindbrain involves segmentation, a strategy that is used to direct 
the diverse range of nerves and craniofacial structures essential to hindbrain function [161]. Hindbrain 
segments called rhombomeres (r), are transient structures that express a distinct set of cellular and 
molecular  properties, including  an ordered pattern  of Hox  gene  expression. Using the VAD  quail 
model,  the  Maden  and  Zile  laboratories  first  observed  that  the  posterior  region  of  the  hindbrain 
(rhombomeres 4–7) does not develop in VAD embryos [162]. The effect of depleting vitamin A by a 
number of means in a variety of organisms was then studied in great detail. Loss of function mutation 
of RALDH2 in both mice and zebrafish results in anteriorization of the hindbrain [163–165]. VAD rat 
embryos generated by severely restricting the amount of RA fed to deficient mothers at the beginning 
of pregnancy results in a loss of posterior rhombomere segmentation, with a significant shortening of 
the hindbrain [65]. In addition, ectopic otic-like vesicles appear posterior to the orthotopic vesicle. By 
varying the amount of RA added back to the maternal diet, this study provided evidence that an 
increasing amount of retinoid is needed for the correct specification of more posterior rhombomeres.  
RARα/γ  compound  mutants  show  a  hindbrain  phenotype  similar  to  that  seen  in  vitamin  A 
deficiency [166], whereas the RARα/β compound null mutants present a less severe phenotype [167], 
indicating  that  RARα  and  RARγ  play  an  important  role  at  early  stages  of  hindbrain  patterning. 
Elimination of all RARs in zebrafish severely disrupts hindbrain patterning [168]. Using cultured chick 
embryos treated with RAR antagonist at various stages of development, distinct developmental time 
windows were identified when RA specifies specific rhombomeres in a rostrocaudal sequence [169].  
The RA needed for antero-posterior patterning is produced in the anterior paraxial mesoderm by 
RALDH2 and diffuses into the adjacent central nervous system (Figure 4A). After this, Raldh2 mRNA 
is found in somitic as well as presomitic mesoderm, but not in the node [170]. The generation and 
diffusion of RA has been proposed to form a gradient (higher caudal/lower rostral) that patterns the 
hindbrain. However, the ability of exogenous RA to rescue development implies that mechanisms 
other than simple diffusion of RA from a localized posterior source must be involved in generating 
differential responsiveness along the hindbrain anterior to posterior axis.  Nutrients 2011, 3  
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Figure 4. Schematic showing the location of RA and Cyp26 expression in a presomitic 
mouse  embryo  undergoing  (A)  patterning  of  the  neural  plate  and  (B)  later  during  the 
course of hindbrain patterning. (A) RA generated by RALDH2 in the posterior mesoderm 
forms an early anterior boundary of activity in the neural plate at presumptive rhombomere 
(pr)  2/pr3,  whereas  Cyp26A1  and  Cyp26C1  are  expressed  rostral  to  the  pr2  border;  
(B)  By  E8.0  to  E8.5,  RA  is  being  expressed  by  the  somites  and  anterior  presomitic 
mesoderm, and acts on the overlying hindbrain and spinal cord. The activity of the CYP26 
enzymes regulate access of the neuroepithelium to RA (Adapted from [139]). 
 
The importance of CYP26 family members in restricting access of the developing hindbrain to RA 
was first exemplified by genetic ablation of CYP26A1, resulting in hindbrain posteriorization. The 
rhombomere-specific expression pattern of the Cyp26 mRNAs led to the proposal that boundaries of 
RA  activity  are  created  by  their  expression  [23,141,171]  (Figure  4B).  For  example,  Cyp26A1  is 
initially expressed in the anterior epiblast and neural plate [18] and forms a boundary at presumptive 
r2/r3  [141].  This  is  followed  by  the  later  expression  of  Cyp26A1  in  r2  and  Cyp26C1  in  r2  and 
r4 [18,21,139,144].  Accordingly,  CYP26A1  mutants  show  hindbrain  abnormalities  just  rostral  
to the region affected by retinoid deficiency, including posterior transformation of r2/3 to a r4-like 
character [139,140], however, individual CYP26B1 and CYP26C1 mutants develop normally [143,144]. 
A series of detailed studies using mouse embryos carrying the RARE-lacZ transgene led to a further 
posit that the initial gradient of RA entering the posterior hindbrain is converted into RA boundaries 
that shift over time [172]. It was proposed that CYP26C1 could play a role in restricting RA activity to 
the rhombomere 4/5 border, although CYP26C1 null mutants reportedly do not show abnormalities at 
this boundary as assessed by HoxB1 and RARE-lacZ staining [144]. However, CYP26A1/C1 double 
knockouts  do  exhibit  even  more  severe  hindbrain  abnormalities  than  CYP26A1  mutants  alone, 
including  a  grossly  enlarged  posterior  hindbrain  at  the  expense  of  anterior  structures  [144]. 
Interestingly, in Cyp26 morpholino studies in zebrafish, restriction of the RA-responsive gene, Vhnff1, 
is  determined  by  the  posterior  limit  of  Cyp26C1  at  the  r4/r5  boundary,  a  function  that  can  be 
compensated for by CYP26B1 [173]. Thus, the combined action of these enzymes along with the 
dynamic changes in where they are expressed during development must prevent RA from reaching 
specific anterior structures. Although not identical, recent models explaining how RA patterns the Nutrients 2011, 3  
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developing  hindbrain  all  include  an  important  role  for  CYP26  family  members  in  regulating  the 
formation of waves or pulses of RA in this dynamic process [23,144,172,173].  
When hindbrain patterning is underway, exposure of the anterior brain to RA is prevented by the 
action of CYP26A1 and CYP26C1, and loss of CYP26A1 renders embryos more sensitive to the 
teratogenic effects of excess exogenous RA on head truncation [174]. By regulating levels of RA in 
the anterior brain, the CYPs may enable a ligand independent function of the RARs. Based on studies 
in Xenopus embryos, unliganded RARs in the head region at this early time are proposed to function as 
transcriptional repressors, that if activated inappropriately by RA, lead to activation of target genes that 
should remain off [175]. Thus, teratogenesis may result from over activation of genes that are normally 
upregulated by RA and/or a loss of gene repression by unliganded RAR. 
A role for RA in forebrain patterning was initially proposed based on studies in chick embryos 
exposed to RAR and RXR antagonists [176] and from the VAD quail model in which the size of the 
telencephalic vessel is reduced and the diencephalon is abnormally patterned [177]. Additional studies 
in  VAD  quail  indicated  that  the  vitamin  was  needed  to  correctly  position  anterior  and  dorsal 
boundaries in the forebrain via modulation of FGF8 and Wnt signaling [178]. RA was also reported in 
chick to contribute to regionalization of the telencephalon along the dorsoventral axis, and RALDH3 
produced by the head ectoderm was proposed as the retinoid source  [179]. However, RALDH2/3 
compound null mutant mice reportedly do not show defects in the early molecular determinants of 
forebrain patterning [178,180]. Instead, Molotkova and colleagues propose that RA functions at later 
times in forebrain development, and provide evidence that RA generated by RALDH3 in the lateral 
ganglionic eminence is required for normal expression of the dopamine D2 receptor in the nucleus 
accumbens and medial striatum [180]. 
Additional roles for RA in later development of the central nervous system (CNS) are beginning to 
emerge [181]. McCaffery’s group found that RA is produced by RALDH2 in the meninges overlying 
the hindbrain at mouse embryonic day 13, and that RA activity as assessed by RARE-lacZ is present in 
precerebellar neurons migrating around the hindbrain circumference to form the inferior olive and 
pontine nuclei [182]. This group went on to show that RA is required for the generation of posterior 
neurons in the inferior olive, as the posterior inferior olive is significantly smaller in late VAD rat 
embryos compared to vitamin A-sufficient controls [183]. In the meninges covering the cortex, levels 
of Raldh2 increase in the mouse embryo from E13 to E14 onward, to a maximal level in the newborn 
brain [184]. Recently, RA from the meninges was reported to function in cortical development by 
regulating  the  switch  of  radial  glia  cells  in  the  ventricular  zone  from  symmetric  to  asymmetric 
division,  resulting  in  the  formation  of  neurons  or  intermediate  progenitor  cells  [185].  It will  be 
important to determine whether RA regulates stem cell division/differentiation in any other areas of 
the CNS. 
3.7. Spinal Cord and Other Neuronal Development 
RA plays a role in the development of caudal structures, including the neural tube that forms the 
spinal cord and in somite development. These tissues arise from the node-streak border, a region that 
comprises the caudal end of the node and the rostral end of the primitive streak [186]. Although primary 
neurulation occurs in both RALDH2 mutant mice and VAD chick and rat embryos [65,123,187], the Nutrients 2011, 3  
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RALDH2 mutant is reported to have a thinner neuroepithelium [149] and VAD quail embryos have 
fewer spinal cord neurons and smaller somites [162,188]. Raldh2 is first expressed during gastrulation 
in  the  mesenchyme  adjacent  to  the  node  and  the  primitive  streak  [148].  In  the  mouse  and  chick 
embryonic  axis,  RA  from  the  anterior  presomitic  mesoderm  and  somites  promotes  neural 
differentiation by inhibiting the expression of Fgf8 [189]. In RALDH2 mutants, primitive streak and 
mesodermal  markers  are  expanded  at  the  expense  of  those  representative  of  the  prospective 
neuroepithelium [149].  
RA from the adjacent somites is needed to generate certain interneurons and ventral spinal cord 
motor neurons [190,191]. RA generated from within the spinal cord is required for the differentiation 
of  a  subset  of  lateral  motor  column  (LMC)  neurons  that  extend  axons  into  the  limb  [192,193]. 
Interactions  between  HOXD10,  which  defines  rostral  boundaries  of  the  lumbosacral  LMC,  and 
HOXD11, which opposes the effects of HOXD10, influence the distribution of motor neuron subtypes 
along the rostrocaudal axis. HOXD11 may also serve to restrict RALDH expression to regions where it 
is needed to support LMC neuron survival and maturation [194].  
There  is  evidence  that  RA  promotes  the  survival  of  sympathetic  neurons  by  inducing 
responsiveness  to  neurotrophins  [195–197].  RA  is  also  linked  to  the  promotion  of  neurite 
outgrowth [157,162]. Recently, a number of genes including neuron navigator 2 (Nav2) and Nedd9 
were discovered in a screen for RA-responsive genes in a neuroblastoma cell line that elaborates 
neurites  in  response  to  RA  [198–200].  Nedd9  is  a  direct  downstream  target  of  RA,  whereas  a 
functional RARE has not yet been identified in the Nav2 gene [33]. When NAV2 is knocked down, the 
neuroblastoma cell is no longer able to extend neurites in response to RA [201]. The human Nav2 gene 
can rescue defects in axonal elongation in the C. elegans mutant, UNC-53 (the homolog of Nav2 in the 
worm), and a mouse mutant hypomorphic for NAV2 also shows defects in cranial nerve development 
and  general  neurite  density  [202].  NAV2  may  function  as  a  link  between  actin  remodeling  and 
microtubule dynamics during neurite outgrowth. 
3.8. Eye Development 
Recognition of the importance of vitamin A in eye development first came from the experiments of 
Hale  in  which  piglets  from  deficient  mothers  were  born  blind  [86,87].  The  morphologic  
consequences of vitamin A deficiency in rat embryos were examined in great detail by Warkany and 
Scharffenberger [61,88]  and  Wilson  et  al.  [95].  They  noted  dysmorphogenesis  of  the  anterior  eye 
segment, retina and optic disc, although the penetrance of the defects was extremely variable. Using a 
model in which normal development is supported in VAD rat embryos up to embryonic day 10.5  
(12–15 somite stage) with RA and deficiency is induced thereafter, See et al. was able to produce eye 
defects in 100% of embryos which included; coloboma, absence of the anterior chamber of the eye, 
rudimentary iris or loss, fusion of the lens and cornea, thickening of the eyelid tissues, reduced size of 
the conjunctival sac, folding of the retina, absence of the vitreous body and the presence of a fibrous 
retrolenticular  membrane  [67,104].  The  addition  of  retinol  at  E10.5  provided  a  full  rescue  of  all 
defects, showing that all the defects were attributable to retinoid deficiency imposed after this time. 
The addition of a high level of RA after E10.5 dramatically improved eye development, supporting 
that vitamin A acid is the active moiety.  Nutrients 2011, 3  
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The  RA  synthesizing  enzymes,  RALDHs,  show  a  very  dynamic  pattern  of  expression  in  the 
developing eye. In the mouse, Raldh2 (also called V2 activity) is transiently expressed in the optic 
vesicle  neuroepithelium  at  E8.5  [132,148,203],  after  which  Raldh3  (also  called  V1  activity)  is 
expressed in the ventral neural retina and pigmented neuroepithelium [134,204–206] and Raldh1 (also 
called ADH-2) is expressed in the dorsal retina from E9.5 onward [134,207]. RARα is expressed in all 
layers of the developing murine neural retina, whereas RARβ is expressed in the inner nuclear layer 
from  embryonic  day  14  to  postnatal  day  7  [208,209].  Genetic  ablation  of  two  or  more  retinoid 
receptors  in  mice  results  in  eye  defects  that  are  largely  similar  to  those  seen  in  VAD  rat 
embryos [97,209–211].  A  number  of  eye  defects  in  RALDH3  and  RALDH1/3  compound 
mutants [134,135,178] are also similar to those observed in late VAD rat embryos. 
Using the late VAD rat embryo model, it is possible to identify the times when vitamin A must be 
present to support eye development by adding back retinol at successively later times ranging from 
E11.5 to E15.5, and evaluating eye development at E18.5 [104]. A full rescue of all structures is 
achieved if retinol is added by E11.5, whereas addition on or after E14.5 is ineffective. Retinol added 
as late as E13.5 completely prevents retinal folding, formation of a fibrous retrolenticular membrane, 
and loss of the vitreous body but is ineffective in preventing anterior eye segment defects, whereas 
addition by E12.5 improves or rescues the majority of defects in anterior eye segment development 
(absence of anterior chamber, rudimentary iris, corneal-lenticular stalk fusion, and small conjunctival 
sac) and prevents coloboma of the retina and optic disc in the majority of fetuses. This study also 
revealed  that  the  cells  within  the  retina  of  late  VAD  embryos  lose  their  characteristic  shape  and 
orientation along the apical-to-basal axis of the retina, with the appearance of gaps or holes in the 
neural retina that worsen as retinol is added at successively later times. Interestingly, the increase in 
cell adhesion proteins, N-cadherin and β-catenin, that normally occurs with development is not seen in 
VAD retinas. Additionally, a reduction in cyclin D1 labeling is observed in the retina of late VAD 
fetuses, suggesting that cell proliferation is also disrupted. These effects may contribute to retinal 
collapse seen in VAD rat embryos receiving no supplemental retinol, or retinol on or after E14.5. 
Using this temporal model, See et al. also clearly showed that a lack of optic fissure closure does not 
lead to retinal folding/collapse, as a well formed retina is produced by adding retinol at a time that is 
too  late  to  prevent  coloboma  [104].  Retinal  thinning  and  disruption  of  cellular  organization  and 
adhesion is a more likely reason for collapse of the retina seen at late stages of severe deficiency.  
RARα has been reported to be the sole receptor transducing the RA signal in the retina beyond 
E10.5  based  on  the  inability  to  detect  RARE-lacZ  expression  in  the  RARα  null  mutant  mouse 
retina [212]. In the absence of this receptor, however, the mouse retina appears to develop normally 
leading  to  the  conclusion  that  RARα  is  unnecessary  for  the  developing  mouse  retina  [213].  
If RARE-lacZ expression is an accurate readout of all RAR-mediated signaling in the neural retina of 
RARα  null  mutants,  then  the  neural  retina  would  appear  not  to  be  a  direct  target  of  RA  and  its 
receptors.  If  so,  then  it  is  possible  that  adverse  effects  of  vitamin  A  deficiency  on  neural  retina 
development could occur by a loss of paracrine action of RA in a secondary tissue, as is proposed for 
retinoid support of anterior eye segment development (Figure 5). Thus, it is unknown whether RA 
generated in the retina acts locally to regulate retina development. Nutrients 2011, 3  
 
402 
Figure 5. Schematic showing the proposed sites of RA function during eye morphogenesis 
(left) and differentiation (right). At early stages of eye development, RA generated by 
RALDH1 and RALDH3 acts as a paracrine signal binding to RARs located in the perioptic 
mesenchyme to support anterior eye segment development and closure of the optic fissure. 
Pitx2 is a RA/RAR-regulated transcription factor that is required both for anterior eye 
segment  morphogenesis,  as  well  as  closure  of  the  optic  fissure.  At  later  stages  of 
development, RA promotes differentiation of the neural retina. The mechanism is unclear, 
but could involve either a paracrine effect of RA outside of the neural retina, or a direct 
effect on the cells within the retina itself. 
 
The  molecular  basis  for  the  vitamin  A  deficiency-induced  defects  in  anterior  eye  segment 
development and in the appearance of coloboma has been the subject of several recent studies. It does 
not involve abnormalities in dorsoventral patterning genes, but rather, disruption of paracrine signaling 
from the retina to the perioptic mesenchyme. Compound deletion of both RARβ and RARγ in the 
neural  crest  cell-derived  periocular  mesenchyme  using  Wnt1-cre  to  direct  excision  results  in  eye 
defects including abnormalities of the cornea and anterior chamber [134,212]. Similarly, RALDH1/3 
compound null mutants show malformations of the anterior segment of the eye, including agenesis of 
the corneal and iris stroma, agenesis of the anterior chamber and less frequently, coloboma of the 
retina  [134,135].  Thus,  RA  from  retina is  believed  to  signal  in  paracrine  fashion  to  the  perioptic 
mesenchyme  to  support  the  development  of  anterior  eye  structures.  Defects  result  from  the  
loss  of  control  of  programmed  cell  death  in  this  region,  and  by  loss  of  RA-mediated  Pitx2,  
Foxc1,  Eya2  and  Dkk2  expression,  and  subsequent  loss  of  repression  of  Wnt/β-catenin 
signaling [134,135,212,214]. Pitx2 encodes a homeodomain transcription factor that is essential for 
anterior eye segment development, and is also required for optic fissure closure [215]. Pitx2 is down 
regulated in the periocular mesenchyme of late VAD embryos that not only show defects in anterior 
eye segment development, but also retinal/optic disc coloboma at 100% penetrance [67,104]. Very 
recently it was shown that the Pitx2 gene contains a RARE located 4.3 kb upstream of the promoter, 
and thus is a direct target of RA and its receptors [214]. Duester and colleagues propose that RA Nutrients 2011, 3  
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signaling activates Pitx2 in the perioptic mesenchyme, which in turn, induces Dkk2 and suppresses 
local Wnt signaling in the regulation of normal anterior segment development. Zacharias et al. has 
extended  this  model  to  include  a  role  for  canonical  Wnt  signaling  in  the  maintenance  of  Pitx2 
expression after its initiation by RA, and prior to the time that Wnt signaling is suppressed [216]. 
3.9. Somites and Skeleton 
RA plays a role in the initiation of differentiation of the anterior region of the presomitic mesoderm 
from which the new somites originate [217]. VAD quail embryos have smaller somites than their  
vitamin  A-sufficient  counterparts,  and  also  have  an  expanded  FGF8  domain  in  the  presomitic  
mesoderm [188]. In RALDH2 null mutants, the expression of Fgf8 mRNA in the primitive ectoderm 
(epiblast) is shifted anteriorly such that it enters the node ectoderm and neuroectoderm, and somite 
development is abnormal [170]. FGF signaling is important in the process of somitogenesis, and the 
opposition of FGF and RA signaling is also important in regulating somite size. A reduction in FGF in 
the  presomitic  mesoderm  below  a  threshold  value  is  needed  to  position  the  future  somite 
boundary [218,219]. Higher levels of FGF8 and Wnt3a signaling maintain cells in an undifferentiated 
state, whereas exposure to RA along with lower FGF8 and Wnt3a initiates differentiation, and these 
factors are believed to control the developmental switch at this boundary [217]. Recent work in chick 
indicates that RA may also be involved in the termination of the process of segmentation [220]. 
RA signaling is involved both in the specification of the axial identity of future somites as well as in 
later stages of skeletal development. Somites, although similar by appearance, develop into distinct 
structures dependent upon their axial position. Determination of initial axial identity is believed to 
occur in mesodermal cells prior to somite formation [221]. VAD rat embryos show anterior vertebral 
transformations throughout the axial skeleton that can be rescued only if vitamin A is provided on or 
before embryonic day 8.75, a time that precedes appearance of the first somite [66]. Genetic deletion 
of several RARs produces defects in axial development with anterior cervical transformations similar 
to VAD embryos [53,97,209]. However, in these mutants, either posteriorization at the cervical/thoracic 
junction is observed, or no vertebral changes caudal to this region are reported [97,209]. Alteration of 
Hox gene expression appears to be major way in which retinoids affect positional information along 
the anteroposterior body axis [222–225]. 
Vitamin A is also required for skeletal development beyond its role in presomitic embryos. Rat 
embryos given sufficient RA up to embryonic day 10.5 (approximately the 12–15 somite stage), but 
made deficient thereafter exhibit hypoplastic cranial bones, defects of the thyroid, cricoid and tracheal 
cartilages as well as agenesis of the neural arch of cervical vertebrae 1 (C1) and ectopic bone in the 
dorsal regions of C1 [67]; defects in this region bear many similarities to those observed in RARα/γ 
compound null mutants [97,98]. Late VAD rat embryos also exhibit gross malformation of the sternal 
and pelvic regions [67]. Sternal malformations have been reported in RBP null mutant embryos from 
RBP null mothers fed inadequate vitamin A [110]. Surprisingly, late VAD rat embryos have anterior 
vertebral transformations in the cervical axial skeleton up to and including the thoracic juncture, along 
with posteriorization events at the thoracic and sacral levels of the skeleton [67]. As discussed above, a 
number  of  RAR  mutants  show  both  cervical  anteriorizations  and  posteriorization  at  the  cervical 
thoracic junction [97,209]. It is also interesting that administration of excess RA to the mouse at E7 Nutrients 2011, 3  
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(presomitic; equivalent to E8.5–9 rat) produces posteriorizing transformations throughout the skeleton; 
however, excess RA at E8.5 (equivalent to E10–10.5 rat), produces anterior transformations starting at 
vertebrae  15  (thoracic vertebra  8, T8)  whereas  excess  RA  at  even  later  times,  yields  both  rostral 
posteriorizing and caudal anteriorizations [223,224]. Thus, vertebral identities, initially specified at the 
late primitive streak phase, can also be respecified at later times in mouse development when the 
vertebrae precursors (the somites), differentiate, and the sclerotome cells begin to form vertebrae. 
In summary, vitamin A plays a normal role in the maintenance of vertebral identity as well as in the 
development of skeletal elements. 
Much of the craniofacial skeleton originates from neural crest cells [226]. Frontonasal agenesis has 
been  reported  in  compound  RAR  null  mutant  mice  [97]  and  RBP  null  mutant  mice  on  a  
vitamin A-deficiency diet [110]. Dupe and Pellerin recently showed that selective ablation of RARα 
and  RARγ  subtypes  using  the  Wnt1-Cre  promoter  leads  to  agenesis  of  the  frontonasal  skeletal 
elements, but does not appear to adversely affect the early survival and migration of neural crest 
cells [227].  Deletion  of  all  three  RAR  subtypes  using  the  selective  promoter  produces  a  similar 
phenotype,  indicating  that  RARα  and  RARγ  act  cell-autonomously  in  neural  crest  cells  to  direct 
morphogenesis of these skeletal elements.  
3.10. Heart Development 
Cardiac and aortic arch defects were observed as a part of the early vitamin A deficiency syndrome 
in rat embryos [93,94] and in RAR compound null mutant mouse embryos [98,102]. When severe 
VAD  is  imposed  in  quail,  the  initiation  of  heart  morphogenesis  is  disrupted  [88,228,229].  
In  VAD  quail  embryos,  vascular  networks  are  absent  and  the  heart  appears  ballooned  and  
non-compartmentalized, and is randomly-positioned without an inflow tract at the posterior site [228]. 
Inability of the heart tube to undergo looping is also observed in RALDH2 mouse mutants [230]. The 
sinuatrial (venous) valve, a transient structure that flanks the orifice between the sinus venosus and 
right atrium, is not formed properly in rat embryos deprived of RA for one day (E9.5–10.5), and 
results  in  improper  channeling  of  venous  blood  and  anterior  cardinal  vein  distension  [64].  If  RA 
deficiency  is  imposed  after  E10.5  in  the  rat  embryo,  a  time  when  the  cardiac  primordium  has 
completed looping and the primitive vasculature is established, early cardiac and aortic arch defects 
are not observed [67]. In summary, roles for vitamin A in mammalian heart development include: 
heart  tube  patterning  and  looping,  chamber  and  outflow  tract  septation,  ventricular  trabeculation, 
cardiomyocyte  differentiation  and  coronary  vessel  development  [231–233].  A  more  in  depth 
discussion of the molecular pathways involved in heart morphogenesis can be found in several recent 
reviews [229,232,234]. 
3.11. Kidney and Urinary Tract Development  
The requirement for RA in the developing kidney and urogenital tract has been illustrated in several 
animal models. In rodents, maternal vitamin A deficiency results in embryonic renal hypoplasia, the 
severity of which depends on the extent of vitamin A deprivation [67,91,110,235]. Ectopic kidneys, 
renal fusion and failure of the renal pelvis and calyx to undergo dilatation, in addition to ectopic 
ureteric openings and other genitourinary tract defects have been reported in VAD rat fetuses [67,91]. Nutrients 2011, 3  
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RALDH2  null  mutant  mice  lack  nephric  ducts  [123]  and  in  RARα/β2  double  receptor  mutants, 
nephron progenitors, stromal cells and ureteric bud tips are all greatly reduced or completely absent at 
birth  [98,236].  These  compound  RAR  mutants  also  have  incorrectly  positioned  distal  ureters, 
hydronephrosis and megaureter. 
Signaling  between  the  ureteric  bud  epithelium  that  forms  the  collecting  duct  system,  the 
metanephric  mesenchyme  that  differentiates  into  nephron,  and  the  stromal  mesenchyme  that 
differentiates  into  the  renal  interstitium  is  important  during  early  kidney  development.  In  the 
embryonic  kidney,  Raldh2  is  localized  in  stromal  mesenchyme  of the  outer  cortex  and  Raldh3  is 
expressed  in  the  ureteric  bud  [130,237,238].  RA  and  its  receptors  are  needed  to  maintain  Ret 
expression [237], a gene critically required for formation of the ureteric bud and its branching in the 
kidney [239–241]. The forced expression of Ret in ureteric bud cells in RARα/β2 double receptor 
mutants rescues renal development, restoring ureteric bud growth and stromal cell patterning [237]. 
Recent work shows that RA generated by RALDH2 in stromal mesenchyme acts in paracrine fashion 
to activate RA-receptor signaling and Ret expression in ureteric bud cells [242].  
In kidney, the number of embryonic branching events determines the final number of nephrons an 
individual  will  have  for  life,  and  it  has  been  proposed  that  suboptimal  nephron  number  at  birth 
increases susceptibility to acquired renal disease and essential hypertension later in life [243–246]. 
Studies in rodents suggest that even mild vitamin A deficiency (a 50% decrease in circulating vitamin 
A  concentrations)  can  lead  to  impaired  branching  and  a  20%  reduction  in  the  number  of 
nephrons [235]. Quite remarkably, a single injection of RA to a control group of pregnant rats at 
midgestation (E11) led to supernumerary nephron endowment in the kidneys of their offspring. RA 
given intraperitoneally at E11.5 is also able to increase nephron endowment in offspring exposed to 
maternal protein restriction without affecting body weight or kidney size, such that the number of 
nephrons per volume of kidney tissue is increased in these rat pups above that seen in the kidneys of 
control offspring [247]. Hence mild vitamin A deficiency in pregnancy may correlate to sub-clinical 
deficiencies in nephron number and slight nephron deficits that are not recognized at birth, but could 
possibly contribute in the long-term to renal failure and hypertension.  
3.12. Diaphragm 
The diaphragm functions as the primary muscle of respiration and forms a physical barrier between 
the thoracic and abdominal cavities. Congenital diaphragmatic hernia (CDH) occurs in approximately 
one in 3000 births, and is associated with high neonatal mortality [248]. Vitamin A is essential for 
normal diaphragm development, and it has been hypothesized that disruption of retinoid signaling may 
contribute to the etiology of the human disorder. A recent report shows that there is a relationship 
between low cord retinol and RBP levels and CDH in newborn infants [249].  
A herniated diaphragm was observed as a part of the early vitamin A deficiency syndrome [89], and 
appears at a 100% penetrance in RA-supported VAD embryos given insufficient RA after E10.5 of 
development, whereas a normal diaphragm results if the mother is supplemented with retinol after this 
time [67]. Diaphragmatic hernia is also observed at low penetrance in RARα/β compound null mutant 
mice [98]. Congenital diaphragmatic hernia in humans is linked to mutations in Stra6, which encodes Nutrients 2011, 3  
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for a membrane RBP receptor [26,250], as well as to CDH-affected chromosome loci encoding for 
several other retinoid-related genes [251].  
The pleuroperitoneal fold (PPF) is a transient structure formed at the union of the pleuro-pericardial 
folds and the septum transversum and represents the component of the primordial diaphragm through 
which muscle precursor cells and pioneer axons of the phrenic nerve migrate to form the mature 
diaphragm. The PPF is fully formed by E13.5 in vitamin A-sufficient rat embryos, but it is abnormal in 
late VAD embryos [252]. Similar defects in PPF development are seen in rat embryos treated with 
nitrofen and several other CDH-inducing teratogens that interfere with the synthesis of RA and RA 
signaling in vivo [253,254]. Raldh2 mRNA is expressed in the PPF, and RARs α, γ and RXRα are 
most strongly expressed in the nonmuscular mesenchymal cells of the PPF. Thus, vitamin A signaling 
in the developing PPF appears to play a key role in the developing diaphragm. 
3.13. Lung and Upper Respiratory Tract and Airways 
Respiratory  defects  including  left  lung  agenesis,  bilateral  lung  hypoplasia,  and  agenesis  of  the 
esophagotracheal septum were described in early VAD syndrome embryos but were characterized as 
rare anomalies [90,95]. Lung hypoplasia is observed with 100% penetrance in rat embryos in which 
RA deficiency is imposed after E10.5, and the severity is increased as RA in the maternal diet is 
reduced [67]. Rars are expressed throughout lung development and RAR compound null mutant mice 
(RARα/β)  show  left  lung  agenesis  and  hypoplasia  [209].  Additionally,  a  wide  array  of  RA 
synthesizing, metabolizing and binding proteins are found in developing lung [255–257]. Mice null for 
RALDH2 or RDH10, also have lung agenesis or hypoplastic phenotypes [122,258,259]. The lung is 
second only to the liver as the major retinoid storage organ [260]. 
The lung arises from foregut endoderm during early development of the embryo. RA from the 
splanchnic mesoderm surrounding the foregut endoderm has been found to be essential for primordial 
lung bud formation at E9.5 in the mouse [256,258,259,261]. It was recently shown that in the foregut 
mesoderm, RA controls the Fgf10 expression required for bud formation by balancing the activation of 
canonical Wnt signaling through direct transcriptional repression of its antagonist Dkk1, and repression 
of Tgfβ signaling [262]. This conclusion is reinforced by work showing that simultaneous activation of 
Wnt and repression of Tgfβ in RA-deficient foregut rescues lung bud formation.  
While RA signaling is required for initial budding, by E10.5–E11.5, as secondary buds form, levels 
are down regulated by the appearance of the RA-degrading enzyme CYP26A1 to enable more distal 
branching and distal airway formation to proceed to completion [256,263]. A role for RA in alveoli 
formation is supported by the finding that RARs are required for correct lung alveoli septation, and 
reports that exogenous RA can stimulate alveoli formation in immature rat and mouse lung [264–269]. 
Figure 6 summarizes the proposed functions of RA in lung development. 
A recent report in the New England Journal of Medicine showed that, in a region with endemic 
vitamin  A  (retinol)  deficiency,  children  whose  mothers  had  received  vitamin  A  supplementation 
before, during, and for 6 months after pregnancy had better lung function when they were tested at 9 to 
11 years of age than children whose mothers had received beta carotene supplementation or placebo. 
Additionally,  they  found  that  the  period  during  which  supplementation  with  vitamin  A  was  most 
important was from gestation through a postnatal age of 6 months [270]. Nutrients 2011, 3  
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Figure 6. Schematic showing the proposed sites of RA action in lung development. In the 
developing embryo, RA is needed for primary bud formation (grey oval), but signaling is 
down-regulated during the time that lung differentiation occurs. A later role for RA in 
alveolar formation (grey oval) is also proposed. During induction of the lung buds, RA 
regulates mesodermal Fgf10 levels by negatively regulating Tgfβ and enabling induction of 
the Wnt pathway by repression of the Dickkopf homolog 1 (Dkk1) known to antagonize 
Wnt ligand-receptor binding. RA may also influence the response of the foregut endoderm 
(origin of lung progenitors) to Fgf10. (Adapted from [262]). 
 
RA acting through the RAR is also necessary for the morphogenesis of other components of the 
respiratory tract including partitioning of the primitive foregut into oesophagus and trachea, and for the 
opening between the nasal and oropharyngeal cavities [67,131,209,256,258,261]. 
3.14. Pancreas 
Although not observed either as a part of the vitamin A deficiency syndrome or in compound RAR 
null mutant mice, a requirement for RA in pancreatic development has been proposed based on studies 
in RALDH null mutant mice [271,272] and in several other organisms in which retinoid signaling is 
deficient or inhibited, including Xenopus, zebrafish, chick, and quail [273–276]. RDH10 knockout 
mice do not have a pancreas [122]. RA produced by RALDH2 is required for early development of the 
dorsal pancreas in the mouse [271,272]. Specification of dorsal pancreatic tissue can be rescued in  
RALDH2-deficient embryos by low-dose maternal administration of RA.  
The effects of RA deficiency on pancreatic lineages appear to be due to the loss of pancreatic field 
specification within the endoderm [274]. Specification of the pancreas occurs between E8.0–8.5 of 
mouse development, and is followed by the development of the dorsal and ventral pancreatic buds at 
E9.0–9.5 [271]. RALDH2 null mutant embryos do not develop a dorsal pancreatic bud. It has been 
suggested that the differential expression of retinoic acid receptors (RARs) in gastrula stage endoderm 
is at least partially responsible for the distinct responsiveness of dorsal versus ventral pancreas [277]. 
Both  defects  in  RA  signaling  and  RA  treatment  have  been  shown  to  affect  the  expression  of  
PDX-1 [271,272,275,278]  an  essential  regulator  of  early  pancreas  development  required  for  the Nutrients 2011, 3  
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pancreatic buds to grow and differentiate [279–281]. RALDH2 mutant embryos lack PDX1 expression 
in dorsal but not ventral endoderm [271,272]. Conversely, exogenous RA has been shown to expand 
the pancreatic field [273–275], and CYP26A1 has recently been shown to play a critical role in setting 
the anterior limit of the pancreas field endodermal Cyp26 expression [282]. Additional information 
regarding the role of RA in pancreas development can be found in several recent reviews [283,284]. 
3.15. Limb Development and Interdigital Cell Death 
Functions for RA in limb development have been forwarded and debated for many years. Inhibitors 
of RA synthesis and vitamin A deficiency inhibit limb outgrowth in the quail [285,286]. In the absence 
of RALDH2, murine forelimb buds do not develop and embryonic growth ceases prior to the stage 
when hindlimb buds are initiated [287,288]. Zebrafish RALDH2 mutants lack pectoral fins and fin bud 
induction does not occur [164,165,276,289]. Limb defects in mice also result from treatment with 
excess exogenous RA, or inappropriate exposure to endogenous levels of RA due to the absence of 
CYP26B1. These studies show that controlled exclusion of RA from the limb bud is essential for 
proper limb morphology [142].  
RA has been proposed to play a role in patterning the developing limb by regulating the pattern of 
expression of genes such as Hand2 (activates SHH), Shh (patterns the anterior-to-posterior axis), and 
Meis1/2  (transcription  factors  that  mark  the  proximal  limb  bud  mesenchyme)  [287,290–292]. 
However,  a  new  report  from  Zhao  and  colleagues  using  a  RALDH2/3  double  mouse  knockout 
suggests that RA acts as a permissive signal at an earlier stage to allow limb bud initiation rather than 
acting in an instructive manner, and that the role of RA is to antagonize early axial FGF signals which 
otherwise inhibit the limb field [80,141,293]. According to this new model, RA signaling within the 
forelimb bud proper is not required for normal patterning to occur. A similar idea was proposed by 
Gilbert et al., who found that axial retinoic acid signals played a permissive role in the induction  
of  zebrafish  pectoral  fins  [289].  RA  appears  to  be  dispensable  for  hindlimb  budding  and 
patterning [80,287]. It is notable that trex embryos carrying a mutation in Rdh10, have small, abnormal 
forelimbs but have hindlimbs that are relatively unaffected [122]. 
At later stages of development, RA is also essential for interdigital cell death, the mechanism by 
which digit separation occurs. Webbed digits have been described in compound RAR mutant mice due 
to  a  loss  of  apoptosis  [209,294].  Around  E12.5  (mouse)  RA  signaling  becomes  confined  to  the 
interdigital zones by a combination of interdigital Raldh2 expression and Cyp26B1 expression in the 
developing digits [295]. The mechanism by which RA activates cell death is currently a subject of 
active investigation [294–297].  
4. Conclusions 
In summary, the vitamin A metabolite, RA, is essential for reproduction in both the male and 
female, as well as for many events in the developing embryo. Nutritional as well as genetic approaches 
are being used to identify the cell types and pathways that are dependent upon RA signaling in support 
of these processes. Paracrine signaling appears to play a prominent role in RA action. Regulation of 
RA synthesis as well as its catabolism is important in determining when and where RA signaling will 
be  activated.  Future  studies  are  needed  to  develop  a  more  detailed  understanding  of  when  in Nutrients 2011, 3  
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development,  and  in  what  specific  cell  types  RA  and  its  receptors  are  acting.  Elucidation  of  the 
pathways that are involved in support of vitamin A functions in stem/germ cell division/differentiation, 
patterning and tissue/organ development remain major tasks for future work.  
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